Anuzis Claims CMS Demo Conceals Real Expenses of Inflation Reduction Act, Reports Detroit News

TL/DR –

Saulius Anuzis, in an opinion piece for Detroit News, criticizes a CMS demonstration project claiming it will hide the true costs of the Inflation Reduction Act. He argues that the act’s proposed inflation penalties will discourage pharmaceutical investment in innovation and limit patient access to life-saving drugs. Anuzis believes that the CMS demo project will obscure these negative impacts, citing concerns over the government’s lack of transparency and accountability.

Anuzis: CMS Demonstration Masking Actual Expenses of Inflation Reduction Act

In a recent report, Anuzis discusses how the CMS demo is potentially concealing the true financial implications of the Inflation Reduction Act. This insightful news piece provides an in-depth analysis of the mechanisms of the CMS demo and their impact on the cost of the Inflation Reduction Act.

Read More US Economic News